期刊文献+

螺旋CT在肝脏双期扫描中延迟时间的设置与应用研究

Study on the Dual Scanning Phase and Time of Monoslice Spiral CT in the Liver
下载PDF
导出
摘要 目的:探索螺旋CT在肝脏增强扫描时的最佳期相的延迟时间的设置。材料与方法:对160例不同身高、体重的患者采用"三定"即定速、定量、定时间的CT俭查方法:进行检查。结果:选用上述两期CT增强扫描延迟设置,可获得满意的影像学信息结论:本法对肝脏CT定性诊断具有非常重要的应用价值。 Purpose:To study the optimal time during the liver-enhancing scanning.Materials and Methods:160 patients were scanned al a certain speed,volume of the contrast and certain time.Results:The peak enhancing time of the hepatic artery phase was 22 ~25s,and the potal vein phase was 55 -60s.Conclusion:The dual scanning can provide detailed and important information for clinician.
出处 《现代医用影像学》 2012年第2期92-94,共3页 Modern Medical Imageology
关键词 双期扫描 动脉期 门脉期 图像后处理 Dual scan Hepatic artery phase Polal vein phase Image postprocessing
  • 相关文献

参考文献4

二级参考文献26

  • 1汪登斌,周康荣,陈克敏,陈憩,展颖,唐永华.MRI MnDPDP增强对原发性肝细胞癌的诊断价值[J].中国医学影像学杂志,2002,10(1):1-4. 被引量:3
  • 2[3]Low RN,Francis IR,Sigeti JS,et al.Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo,and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging.Radiology,1993,186:803
  • 3[4]Whiteney WS,Herfken RJ,Jeffrey RB,et al.Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with Gadolinium-enhancement for differentiating hepatic hemangiomas from malignancies at 1.5T.Radiology,1993,189:863
  • 4[5]Fujita T,Ito K,Honjo K,et al.Detection of hepatocellular carcinoma: comparison of T2-weighted breath-hold fast spin-echo sequences and high-resolution dynamic MR imaging with a phased-array body coil.J Magn Reson Imaging,1999,9:274
  • 5[7]Toft KG,Hustvedt SO,et al.Metabolism and pharmacokinetics of Mn-DPDP in man.Acta Radiologica,1997,38:677
  • 6[8]Hannhn PF and Saini S.Liver-specific MR imaging contrast agents.Radiol Clini Nor Am,1998,36:287
  • 7[9]Kirchin MA,Pirovano GP,Spinazzi A.Gadobenate dimeglumine (Gd-BOPTA): an overview.Invest Radiol,1998,33:798
  • 8[10]Spinazzi A,Lorusso V,Pirovano G,et al.Safety,tolerance,biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.Acad Radiol,1999,6:282
  • 9[11]Kirchin MA,Pirovano G,Venetianer C,et al.Safety assessment of gadobenate dimeglumine (Multihance): extended clinical experience from phase Ⅰ studies to post-marketing surveillance.J Magn Reson Imaging,2001,14:281
  • 10[12]Lorusso V,Arbughi T,Tirone P,et al.Pharmacokinetics and tissue distribution in animals of gadobenate ion,the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance).J Comput Assist Tomogr,1999,1:181

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部